PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.81
ESG score 90-95% of RIGL's 60.88. Bill Ackman would demand clear ESG improvement catalysts.
54.80
Environmental score 90-95% of RIGL's 59.76. Bill Ackman would demand clear environmental improvement catalysts.
57.90
Social score 80-90% of RIGL's 65.58. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
60.72
Governance score 1.1-1.2x RIGL's 57.30. Guy Spier would verify if superior governance translates to better capital allocation and strategic execution.